Antiepileptic Drugs Market - Forecast(2019 - 2024)

Report Code: HCR 0142 Report Format: PDF + Excel (Delivery in 48 Hrs)
Antiepileptic drugs are used to treat patients with epilepsy. Epilepsy is a brain disorder, which leads to a patient having seizures whenever a set of neurons send proper electrical impulses. Epilepsy has a psychological effect on patients which affects their day-to-day activities making otherwise normal day chores a challenge. The cause for epilepsy has still yet not been determined although many believe that drastic lifestyle changes have led to the onset of epilepsy across the globe. Some of these lifestyle changes include smoking, alcohol abuse, drugs abuse etc. Antiepileptic drugs are able to arrest the symptoms of epilepsy to a certain extent. The degree to which the symptoms can be spressed depends on the age of the patient, the degree to which the individual has been affected and the general body constitution of the patient. 

In terms of geographical contribution, the North American region accounts for the highest share of the antiepileptic drugs market. This is due to two main reasons, the first being that the condition of epilepsy was recognized in this region whereas in other regions such as APAC and Latin America, it was not recognized as a condition. Further to this, the level of research, which takes place for neurology is the highest in North America and as such, the reason was one of the first to bring in antiepileptic drugs. As on date, it is estimated that close to 3 million individuals in the United States alone have been recognized as having been affected by epilepsy.  The United States was one of the first few countries, which was able to utilize the second-generation antiepileptic drugs. 

Countries in Asia have now also recognized epilepsy and now possess a huge potential for the antiepileptic drug market. Countries like China, India and Thailand have a large number of cases of epilepsy that are now also being treated with antiepileptic drugs.

Antiepileptic Drugs Market

The Antiepileptic Drugs market can be segmented on the basis of type as
First Generation Drugs:
  • Valproate (Depakote)
  • Oxycarbazepine ((Trileptal)
  • Carbamazepine (Carbatrol)
  • Phenobarbital (Luminal)
  • Primidone (Mysoline)
  • Ethosuximide (Zarontin)
  • Topiramate (Topamax)
Second Generation Drugs:
  • Lamotrigine (Lamictal)
  • Pregabalin (Lyrica)
  • Eslicarbazepine acetate Zonisamide (Zonegran)
  • Lacosamide (Vimpat)
  • Levetiracetam (Keppra)
  • (Aptiom/Zebinix) 
  • Perampanel (Fycompa)
  • Rufinamide (Banzel/Inovelon)
  • Ezogabine/retigabine (Trobalt/Potiga)
Pipeline Drugs: 
  • Buspirone
  • Everoline
  • UCB0942 (PPSI)
  • Lacosamide
  • GWP42006
  • TAK-932
  • Brivaracetam (UCB Pharma Ltd)
  • Ganaxolone (Marinus Pharmaceuticals)
  • USL261 (Upsher Smith Laboratories, Inc.)
  • Perampanel (Eisai Co) 
  • YKP3089 (SK Life Sciences) 

The market has been segmented based on the following geographies:
  • North America
  • South America
  • APAC
  • Europe
  • Middle East 
  • Africa

Sample Companies Profiled in this Report are: 
  • Abbott Laboratories
  • Cephalon
  • GlaxoSmithKline
  • Johnson & Johnson 
  • Novartis AG
  • 10+
1. Antiepileptic Drugs Market - Overview
1.1. Definitions and Scope
2. Antiepileptic Drugs Market - Executive summary
2.1. Market Revenue, Market Size and Key Trends by Company
2.2. Key Trends by type of Application
2.3. Key Trends segmented by Geography
3. Antiepileptic Drugs Market 
3.1. Comparative analysis
3.1.1. Product Benchmarking - Top 10 companies
3.1.2. Top 5 Financials Analysis
3.1.3. Market Value split by Top 10 companies
3.1.4. Patent Analysis - Top 10 companies
3.1.5. Pricing Analysis 
4. Antiepileptic Drugs Market – Startup companies Scenario Premium
4.1. Top 10 startup company Analysis by
4.1.1. Investment
4.1.2. Revenue
4.1.3. Market Shares
4.1.4. Market Size and Application Analysis
4.1.5. Venture Capital and Funding Scenario
5. Antiepileptic Drugs Market – Industry Market Entry Scenario Premium
5.1. Regulatory Framework Overview
5.2. New Business and Ease of Doing business index
5.3. Case studies of successful ventures
5.4. Customer Analysis – Top 10 companies
6. Antiepileptic Drugs Market Forces
6.1. Drivers
6.2. Constraints
6.3. Challenges
6.4. Porters five force model
6.4.1. Bargaining power of suppliers
6.4.2. Bargaining powers of customers
6.4.3. Threat of new entrants
6.4.4. Rivalry among existing players
6.4.5. Threat of substitutes 
7. Antiepileptic Drugs Market -Strategic analysis
7.1. Value chain analysis
7.2. Opportunities analysis
7.3. Product life cycle
7.4. Suppliers and distributors Market Share
8. Antiepileptic Drugs Market – By Type (Market Size -$Million / $Billion)
8.1. Market Size and Market Share Analysis 
8.2. Application Revenue and Trend Research
8.3. Product Segment Analysis
8.3.1. First Generation Drugs
8.3.1.1. Valproate (Depakote)
8.3.1.2. Oxycarbazepine ((Trileptal)
8.3.1.3. Carbamazepine (Carbatrol)
8.3.1.4. Phenobarbital (Luminal)
8.3.1.5. Primidone (Mysoline)
8.3.1.6. Ethosuximide (Zarontin)
8.3.1.7. Topiramate (Topamax)
8.3.2. Second Generation Drugs
8.3.2.1. Pregabalin (Lyrica)
8.3.2.2. Lamotrigine (Lamictal)
8.3.2.3. Eslicarbazepine acetate Zonisamide (Zonegran)
8.3.2.4. Lacosamide (Vimpat)
8.3.2.5. Levetiracetam (Keppra)
8.3.2.6. (Aptiom/Zebinix)
8.3.2.7. Rufinamide (Banzel/Inovelon)
8.3.2.8. Perampanel (Fycompa)
8.3.2.9. Ezogabine/retigabine (Trobalt/Potiga)
8.3.3. Pipeline Drugs
8.3.3.1. Buspirone
8.3.3.2. Everoline
8.3.3.3. UCB0942 (PPSI)
8.3.3.4. GWP42006
8.3.3.5. Lacosamide
8.3.3.6. TAK-932
8.3.3.7. Brivaracetam (UCB Pharma Ltd)
8.3.3.8. Ganaxolone (Marinus Pharmaceuticals)
8.3.3.9. USL261 (Upsher Smith Laboratories, Inc.)
8.3.3.10. Perampanel (Eisai Co)
8.3.3.11. YKP3089 (SK Life Sciences)
8.3.4. Others
9. Antiepileptic Drugs - By Geography (Market Size -$Million / $Billion)
9.1. Antiepileptic Drugs Market - North America Segment Research
9.2. North America Market Research (Million / $Billion)
9.2.1. Segment type Size and Market Size Analysis 
9.2.2. Revenue and Trends
9.2.3. Application Revenue and Trends by type of Application
9.2.4. Company Revenue and Product Analysis
9.2.5. North America Product type and Application Market Size
9.2.5.1. U.S.
9.2.5.2. Canada 
9.2.5.3. Mexico 
9.2.5.4. Rest of North America
9.3. Antiepileptic Drugs - South America Segment Research
9.4. South America Market Research (Market Size -$Million / $Billion)
9.4.1. Segment type Size and Market Size Analysis 
9.4.2. Revenue and Trends
9.4.3. Application Revenue and Trends by type of Application
9.4.4. Company Revenue and Product Analysis
9.4.5. South America Product type and Application Market Size
9.4.5.1. Brazil  
9.4.5.2. Venezuela
9.4.5.3. Argentina
9.4.5.4. Ecuador
9.4.5.5. Peru
9.4.5.6. Colombia 
9.4.5.7. Costa Rica
9.4.5.8. Rest of South America
9.5. Antiepileptic Drugs - Europe Segment Research
9.6. Europe Market Research (Market Size -$Million / $Billion)
9.6.1. Segment type Size and Market Size Analysis 
9.6.2. Revenue and Trends
9.6.3. Application Revenue and Trends by type of Application
9.6.4. Company Revenue and Product Analysis
9.6.5. Europe Segment Product type and Application Market Size
9.6.5.1. U.K  
9.6.5.2. Germany 
9.6.5.3. Italy 
9.6.5.4. France
9.6.5.5. Netherlands
9.6.5.6. Belgium
9.6.5.7. Spain
9.6.5.8. Denmark
9.6.5.9. Rest of Europe
9.7. Antiepileptic Drugs – APAC Segment Research
9.8. APAC Market Research (Market Size -$Million / $Billion)
9.8.1. Segment type Size and Market Size Analysis 
9.8.2. Revenue and Trends
9.8.3. Application Revenue and Trends by type of Application
9.8.4. Company Revenue and Product Analysis
9.8.5. APAC Segment – Product type and Application Market Size
9.8.5.1. China 
9.8.5.2. Australia
9.8.5.3. Japan 
9.8.5.4. South Korea
9.8.5.5. India
9.8.5.6. Taiwan
9.8.5.7. Malaysia
10. Antiepileptic Drugs Market - Entropy
10.1. New product launches
10.2. M&A's, collaborations, JVs and partnerships
11. Antiepileptic Drugs Market – Industry / Segment Competition landscape Premium
11.1. Market Share Analysis
11.1.1. Market Share by Country- Top companies
11.1.2. Market Share by Region- Top 10 companies
11.1.3. Market Share by type of Application – Top 10 companies
11.1.4. Market Share by type of Product / Product category- Top 10 companies
11.1.5. Market Share at global level- Top 10 companies
11.1.6. Best Practises for companies
12. Antiepileptic Drugs Market – Key Company List by Country Premium
13. Antiepileptic Drugs Market Company Analysis
13.1. Market Share, Company Revenue, Products, M&A, Developments
13.2. Abbott Laboratories
13.3. Cephalon
13.4. GlaxoSmithKline
13.5. Johnson & Johnson
13.6. Novartis AG
13.7. Pfizer
13.8. Sanofi S.A
13.9. Sunovion Pharmaceuticals
13.10. UCB Pharma Ltd.
13.11. Valeant Pharmaceuticals International
13.12. Company 12
13.13. Company 13
13.14. Company 14 and More
"*Financials would be provided on a best efforts basis for private companies"
14. Antiepileptic Drugs Market -Appendix
14.1. Abbreviations
14.2. Sources
15. Antiepileptic Drugs Market -Methodology Premium
15.1. Research Methodology
15.1.1. Company Expert Interviews
15.1.2. Industry Databases
15.1.3. Associations
15.1.4. Company News
15.1.5. Company Annual Reports
15.1.6. Application Trends
15.1.7. New Products and Product database
15.1.8. Company Transcripts
15.1.9. R&D Trends
15.1.10. Key Opinion Leaders Interviews
15.1.11. Supply and Demand Trends
List of Tables
Table 1: Antiepileptic Drugs Market Overview 2019-2024
Table 2: Antiepileptic Drugs Market Leader Analysis 2018-2019 (US$)
Table 3: Antiepileptic Drugs Market Product Analysis 2018-2019 (US$)
Table 4: Antiepileptic Drugs Market End User Analysis 2018-2019 (US$)
Table 5: Antiepileptic Drugs Market Patent Analysis 2013-2018* (US$)
Table 6: Antiepileptic Drugs Market Financial Analysis 2018-2019 (US$)
Table 7: Antiepileptic Drugs Market Driver Analysis 2018-2019 (US$)
Table 8: Antiepileptic Drugs Market Challenges Analysis 2018-2019 (US$)
Table 9: Antiepileptic Drugs Market Constraint Analysis 2018-2019 (US$)
Table 10: Antiepileptic Drugs Market Supplier Bargaining Power Analysis 2018-2019 (US$)
Table 11: Antiepileptic Drugs Market Buyer Bargaining Power Analysis 2018-2019 (US$)
Table 12: Antiepileptic Drugs Market Threat of Substitutes Analysis 2018-2019 (US$)
Table 13: Antiepileptic Drugs Market Threat of New Entrants Analysis 2018-2019 (US$)
Table 14: Antiepileptic Drugs Market Degree of Competition Analysis 2018-2019 (US$)
Table 15: Antiepileptic Drugs Market Value Chain Analysis 2018-2019 (US$)
Table 16: Antiepileptic Drugs Market Pricing Analysis 2019-2024 (US$)
Table 17: Antiepileptic Drugs Market Opportunities Analysis 2019-2024 (US$)
Table 18: Antiepileptic Drugs Market Product Life Cycle Analysis 2019-2024 (US$)
Table 19: Antiepileptic Drugs Market Supplier Analysis 2018-2019 (US$)
Table 20: Antiepileptic Drugs Market Distributor Analysis 2018-2019 (US$)
Table 21: Antiepileptic Drugs Market Trend Analysis 2018-2019 (US$)
Table 22: Antiepileptic Drugs Market Size 2018 (US$)
Table 23: Antiepileptic Drugs Market Forecast Analysis 2019-2024 (US$)
Table 24: Antiepileptic Drugs Market Sales Forecast Analysis 2019-2024 (Units)
Table 25: Antiepileptic Drugs Market, Revenue & Volume,By Type, 2019-2024 ($)
Table 26: Antiepileptic Drugs Market By Type, Revenue & Volume,By First Generation Drugs, 2019-2024 ($)
Table 27: Antiepileptic Drugs Market By Type, Revenue & Volume,By Second Generation Drugs, 2019-2024 ($)
Table 28: Antiepileptic Drugs Market By Type, Revenue & Volume,By Pipeline Drugs, 2019-2024 ($)
Table 29: North America Antiepileptic Drugs Market, Revenue & Volume,By Type, 2019-2024 ($)
Table 30: South america Antiepileptic Drugs Market, Revenue & Volume,By Type, 2019-2024 ($)
Table 31: Europe Antiepileptic Drugs Market, Revenue & Volume,By Type, 2019-2024 ($)
Table 32: APAC Antiepileptic Drugs Market, Revenue & Volume,By Type, 2019-2024 ($)
Table 33: Middle East & Africa Antiepileptic Drugs Market, Revenue & Volume,By Type, 2019-2024 ($)
Table 34: Russia Antiepileptic Drugs Market, Revenue & Volume,By Type, 2019-2024 ($)
Table 35: Israel Antiepileptic Drugs Market, Revenue & Volume,By Type, 2019-2024 ($)
Table 36: Top Companies 2018 (US$)Antiepileptic Drugs Market, Revenue & Volume
Table 37: Product Launch 2018-2019Antiepileptic Drugs Market, Revenue & Volume
Table 38: Mergers & Acquistions 2018-2019Antiepileptic Drugs Market, Revenue & Volume

List of Figures
Figure 1: Overview of Antiepileptic Drugs Market 2019-2024
Figure 2: Market Share Analysis for Antiepileptic Drugs Market 2018 (US$)
Figure 3: Product Comparison in Antiepileptic Drugs Market 2018-2019 (US$)
Figure 4: End User Profile for Antiepileptic Drugs Market 2018-2019 (US$)
Figure 5: Patent Application and Grant in Antiepileptic Drugs Market 2013-2018* (US$)
Figure 6: Top 5 Companies Financial Analysis in Antiepileptic Drugs Market 2018-2019 (US$)
Figure 7: Market Entry Strategy in Antiepileptic Drugs Market 2018-2019
Figure 8: Ecosystem Analysis in Antiepileptic Drugs Market 2018
Figure 9: Average Selling Price in Antiepileptic Drugs Market 2019-2024
Figure 10: Top Opportunites in Antiepileptic Drugs Market 2018-2019
Figure 11: Market Life Cycle Analysis in Antiepileptic Drugs Market
Figure 12: GlobalBy TypeAntiepileptic Drugs Market Revenue, 2019-2024 ($)
Figure 13: Global Antiepileptic Drugs Market - By Geography
Figure 14: Global Antiepileptic Drugs Market Value & Volume, By Geography, 2019-2024 ($) 
Figure 15: Global Antiepileptic Drugs Market CAGR, By Geography, 2019-2024 (%)
Figure 16: North America Antiepileptic Drugs Market Value & Volume, 2019-2024 ($)
Figure 17: US Antiepileptic Drugs Market Value & Volume, 2019-2024 ($)
Figure 18: US GDP and Population, 2018-2019 ($)
Figure 19: US GDP – Composition of 2018, By Sector of Origin
Figure 20: US Export and Import Value & Volume, 2018-2019 ($)
Figure 21: Canada Antiepileptic Drugs Market Value & Volume, 2019-2024 ($)
Figure 22: Canada GDP and Population, 2018-2019 ($)
Figure 23: Canada GDP – Composition of 2018, By Sector of Origin
Figure 24: Canada Export and Import Value & Volume, 2018-2019 ($)
Figure 25: Mexico Antiepileptic Drugs Market Value & Volume, 2019-2024 ($)
Figure 26: Mexico GDP and Population, 2018-2019 ($)
Figure 27: Mexico GDP – Composition of 2018, By Sector of Origin
Figure 28: Mexico Export and Import Value & Volume, 2018-2019 ($)
Figure 29: South America Antiepileptic Drugs Market Value & Volume, 2019-2024 ($)
Figure 30: Brazil Antiepileptic Drugs Market Value & Volume, 2019-2024 ($)
Figure 31: Brazil GDP and Population, 2018-2019 ($)
Figure 32: Brazil GDP – Composition of 2018, By Sector of Origin
Figure 33: Brazil Export and Import Value & Volume, 2018-2019 ($)
Figure 34: Venezuela Antiepileptic Drugs Market Value & Volume, 2019-2024 ($)
Figure 35: Venezuela GDP and Population, 2018-2019 ($)
Figure 36: Venezuela GDP – Composition of 2018, By Sector of Origin
Figure 37: Venezuela Export and Import Value & Volume, 2018-2019 ($)
Figure 38: Argentina Antiepileptic Drugs Market Value & Volume, 2019-2024 ($)
Figure 39: Argentina GDP and Population, 2018-2019 ($)
Figure 40: Argentina GDP – Composition of 2018, By Sector of Origin
Figure 41: Argentina Export and Import Value & Volume, 2018-2019 ($)
Figure 42: Ecuador Antiepileptic Drugs Market Value & Volume, 2019-2024 ($)
Figure 43: Ecuador GDP and Population, 2018-2019 ($)
Figure 44: Ecuador GDP – Composition of 2018, By Sector of Origin
Figure 45: Ecuador Export and Import Value & Volume, 2018-2019 ($)
Figure 46: Peru Antiepileptic Drugs Market Value & Volume, 2019-2024 ($)
Figure 47: Peru GDP and Population, 2018-2019 ($)
Figure 48: Peru GDP – Composition of 2018, By Sector of Origin
Figure 49: Peru Export and Import Value & Volume, 2018-2019 ($)
Figure 50: Colombia Antiepileptic Drugs Market Value & Volume, 2019-2024 ($)
Figure 51: Colombia GDP and Population, 2018-2019 ($)
Figure 52: Colombia GDP – Composition of 2018, By Sector of Origin
Figure 53: Colombia Export and Import Value & Volume, 2018-2019 ($)
Figure 54: Costa Rica Antiepileptic Drugs Market Value & Volume, 2019-2024 ($)
Figure 55: Costa Rica GDP and Population, 2018-2019 ($)
Figure 56: Costa Rica GDP – Composition of 2018, By Sector of Origin
Figure 57: Costa Rica Export and Import Value & Volume, 2018-2019 ($)
Figure 58: Europe Antiepileptic Drugs Market Value & Volume, 2019-2024 ($)
Figure 59: U.K Antiepileptic Drugs Market Value & Volume, 2019-2024 ($)
Figure 60: U.K GDP and Population, 2018-2019 ($)
Figure 61: U.K GDP – Composition of 2018, By Sector of Origin
Figure 62: U.K Export and Import Value & Volume, 2018-2019 ($)
Figure 63: Germany Antiepileptic Drugs Market Value & Volume, 2019-2024 ($)
Figure 64: Germany GDP and Population, 2018-2019 ($)
Figure 65: Germany GDP – Composition of 2018, By Sector of Origin
Figure 66: Germany Export and Import Value & Volume, 2018-2019 ($)
Figure 67: Italy Antiepileptic Drugs Market Value & Volume, 2019-2024 ($)
Figure 68: Italy GDP and Population, 2018-2019 ($)
Figure 69: Italy GDP – Composition of 2018, By Sector of Origin
Figure 70: Italy Export and Import Value & Volume, 2018-2019 ($)
Figure 71: France Antiepileptic Drugs Market Value & Volume, 2019-2024 ($)
Figure 72: France GDP and Population, 2018-2019 ($)
Figure 73: France GDP – Composition of 2018, By Sector of Origin
Figure 74: France Export and Import Value & Volume, 2018-2019 ($)
Figure 75: Netherlands Antiepileptic Drugs Market Value & Volume, 2019-2024 ($)
Figure 76: Netherlands GDP and Population, 2018-2019 ($)
Figure 77: Netherlands GDP – Composition of 2018, By Sector of Origin
Figure 78: Netherlands Export and Import Value & Volume, 2018-2019 ($)
Figure 79: Belgium Antiepileptic Drugs Market Value & Volume, 2019-2024 ($)
Figure 80: Belgium GDP and Population, 2018-2019 ($)
Figure 81: Belgium GDP – Composition of 2018, By Sector of Origin
Figure 82: Belgium Export and Import Value & Volume, 2018-2019 ($)
Figure 83: Spain Antiepileptic Drugs Market Value & Volume, 2019-2024 ($)
Figure 84: Spain GDP and Population, 2018-2019 ($)
Figure 85: Spain GDP – Composition of 2018, By Sector of Origin
Figure 86: Spain Export and Import Value & Volume, 2018-2019 ($)
Figure 87: Denmark Antiepileptic Drugs Market Value & Volume, 2019-2024 ($)
Figure 88: Denmark GDP and Population, 2018-2019 ($)
Figure 89: Denmark GDP – Composition of 2018, By Sector of Origin
Figure 90: Denmark Export and Import Value & Volume, 2018-2019 ($)
Figure 91: APAC Antiepileptic Drugs Market Value & Volume, 2019-2024 ($)
Figure 92: China Antiepileptic Drugs Market Value & Volume, 2019-2024
Figure 93: China GDP and Population, 2018-2019 ($)
Figure 94: China GDP – Composition of 2018, By Sector of Origin
Figure 95: China Export and Import Value & Volume, 2018-2019 ($)Antiepileptic Drugs Market China Export and Import Value & Volume, 2018-2019 ($)
Figure 96: Australia Antiepileptic Drugs Market Value & Volume, 2019-2024 ($)
Figure 97: Australia GDP and Population, 2018-2019 ($)
Figure 98: Australia GDP – Composition of 2018, By Sector of Origin
Figure 99: Australia Export and Import Value & Volume, 2018-2019 ($)
Figure 100: South Korea Antiepileptic Drugs Market Value & Volume, 2019-2024 ($)
Figure 101: South Korea GDP and Population, 2018-2019 ($)
Figure 102: South Korea GDP – Composition of 2018, By Sector of Origin
Figure 103: South Korea Export and Import Value & Volume, 2018-2019 ($)
Figure 104: India Antiepileptic Drugs Market Value & Volume, 2019-2024 ($)
Figure 105: India GDP and Population, 2018-2019 ($)
Figure 106: India GDP – Composition of 2018, By Sector of Origin
Figure 107: India Export and Import Value & Volume, 2018-2019 ($)
Figure 108: Taiwan Antiepileptic Drugs Market Value & Volume, 2019-2024 ($)
Figure 109: Taiwan GDP and Population, 2018-2019 ($)
Figure 110: Taiwan GDP – Composition of 2018, By Sector of Origin
Figure 111: Taiwan Export and Import Value & Volume, 2018-2019 ($)
Figure 112: Malaysia Antiepileptic Drugs Market Value & Volume, 2019-2024 ($)
Figure 113: Malaysia GDP and Population, 2018-2019 ($)
Figure 114: Malaysia GDP – Composition of 2018, By Sector of Origin
Figure 115: Malaysia Export and Import Value & Volume, 2018-2019 ($)
Figure 116: Hong Kong Antiepileptic Drugs Market Value & Volume, 2019-2024 ($)
Figure 117: Hong Kong GDP and Population, 2018-2019 ($)
Figure 118: Hong Kong GDP – Composition of 2018, By Sector of Origin
Figure 119: Hong Kong Export and Import Value & Volume, 2018-2019 ($)
Figure 120: Middle East & Africa Antiepileptic Drugs Market Middle East & Africa 3D Printing Market Value & Volume, 2019-2024 ($)
Figure 121: Russia Antiepileptic Drugs Market Value & Volume, 2019-2024 ($)
Figure 122: Russia GDP and Population, 2018-2019 ($)
Figure 123: Russia GDP – Composition of 2018, By Sector of Origin
Figure 124: Russia Export and Import Value & Volume, 2018-2019 ($)
Figure 125: Israel Antiepileptic Drugs Market Value & Volume, 2019-2024 ($)
Figure 126: Israel GDP and Population, 2018-2019 ($)
Figure 127: Israel GDP – Composition of 2018, By Sector of Origin
Figure 128: Israel Export and Import Value & Volume, 2018-2019 ($)
Figure 129: Entropy Share, By Strategies, 2018-2019* (%)Antiepileptic Drugs Market 
Figure 130: Developments, 2018-2019*Antiepileptic Drugs Market 
Figure 131: Company 1 Antiepileptic Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 132: Company 1 Antiepileptic Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 133: Company 1 Antiepileptic Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 134: Company 2 Antiepileptic Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 135: Company 2 Antiepileptic Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 136: Company 2 Antiepileptic Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 137: Company 3Antiepileptic Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 138: Company 3Antiepileptic Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 139: Company 3Antiepileptic Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 140: Company 4 Antiepileptic Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 141: Company 4 Antiepileptic Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 142: Company 4 Antiepileptic Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 143: Company 5 Antiepileptic Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 144: Company 5 Antiepileptic Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 145: Company 5 Antiepileptic Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 146: Company 6 Antiepileptic Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 147: Company 6 Antiepileptic Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 148: Company 6 Antiepileptic Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 149: Company 7 Antiepileptic Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 150: Company 7 Antiepileptic Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 151: Company 7 Antiepileptic Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 152: Company 8 Antiepileptic Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 153: Company 8 Antiepileptic Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 154: Company 8 Antiepileptic Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 155: Company 9 Antiepileptic Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 156: Company 9 Antiepileptic Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 157: Company 9 Antiepileptic Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 158: Company 10 Antiepileptic Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 159: Company 10 Antiepileptic Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 160: Company 10 Antiepileptic Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 161: Company 11 Antiepileptic Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 162: Company 11 Antiepileptic Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 163: Company 11 Antiepileptic Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 164: Company 12 Antiepileptic Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 165: Company 12 Antiepileptic Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 166: Company 12 Antiepileptic Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 167: Company 13Antiepileptic Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 168: Company 13Antiepileptic Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 169: Company 13Antiepileptic Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 170: Company 14 Antiepileptic Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 171: Company 14 Antiepileptic Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 172: Company 14 Antiepileptic Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 173: Company 15 Antiepileptic Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 174: Company 15 Antiepileptic Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 175: Company 15 Antiepileptic Drugs Market Net Sales Share, By Geography, 2018 (%)